Actos is a drug usually prescribed to patients with diabetes to aid in their insulin uptake. However, many ill patients have filed lawsuits against Takeda Pharmaceuticals, the drug’s manufacturer, due to allegations of deadly side effects. A recent study adds legitimacy to the patients’ claims.
A study performed by Jeffrey A. Johnson found that people with diabetes who take Actos are 22 percent more likely to develop bladder cancer than those who abstain from the drug. Of 2.6 million patients taking Actos, 3,643 of them developed bladder cancer.
Actos is intended to help diabetics by making the body’s cells more susceptible to insulin, a growth hormone. Unfortunately, malignant cancer cells also feed on insulin, so Actos can fuel the growth of cancer cells.
The Food and Drug Administration (FDA) says that using Actos for over a year can increase the risk of bladder cancer by 40 percent.
A federal Actos court date is scheduled for November 3, 2014. Due to the sheer number of people affected, the court has scheduled a second Actos liability court date for July 8, 2015.
The drug may have even more severe side effects according to a whistleblower lawsuit filed by Dr. Helen Ge, a former employee. She claims her supervisors advised her to smooth over some of the drug’s more harmful side effects in various reports, which she says includes epilepsy, heart trouble, schizophrenia and suicide.
If you suffered a serious illness after taking Actos or if you lost a family member who was taking the drug, call us at (305) 379-0305. You can also submit a contact form or leave a comment below. There is no charge to discuss your potential case.
Sarelson Law Firm – Miami class action attorneys